Insulin, Human
Also known as: Human Insulin
Use
The Insulin, Human test is utilized to measure the specific IgE antibodies to human insulin. This test is valuable in determining hypersensitivity reactions, especially in patients who have been exposed to human insulin for therapeutic purposes. By evaluating IgE levels, healthcare providers can assess potential allergic responses to insulin, aiding in the management of insulin therapies and monitoring allergic conditions related to insulin use.
Special Instructions
The test uses Thermo Fisher ImmunoCAP® technology, which is a well-established methodology for immunologic testing. Ensure that specimen collection follows proper protocols to maintain stability and accuracy of results.
Limitations
This test specifically measures IgE antibodies to human insulin and may not detect other forms of hypersensitivity or related allergic responses. Biological variability and cross-reactivity with other allergens may affect the test outcomes. The results should be interpreted alongside clinical findings and other diagnostic tests. False positive or negative results can occur and should be considered when making clinical decisions.
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 6148-1
- 6148-1
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.2 mL
Minimum Volume
Not provided
Container
Red-top tube or gel-barrier tube
Storage Instructions
Room temperature
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 3 months |